Design, synthesis and iodination of an Arg-Arg-Leu peptide for potential use as an imaging agent for human prostate carcinoma

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 51, Issue 11, 2008, Pages 374-378

  Yu, MingMing ^a   Wang, RongFu ^a   Yan, Ping ^a   Zhang, ChunLi ^a   Liu, Meng ^a   Cui, YongGang ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Arginine arginine leucine (RRL); Human prostate carcinoma; Peptide; Radioiodination

Indexed keywords

DIAGNOSIS; ION EXCHANGE; PEPTIDES; PURIFICATION; SYNTHESIS (CHEMICAL); TUMORS; UROLOGY;

ARGININE-ARGININE-LEUCINE (RRL); DESIGN SYNTHESIS; HUMAN PROSTATE; HUMAN PROSTATE CARCINOMA; IMAGING AGENT; POTENTIAL IMAGING; PROSTATE CARCINOMA; RADIOIODINATION; SYNTHESISED; TUMOR ANGIOGENESIS;

ARGININE;

ARGINYLARGINYLLEUCINE I 131; IODINE 131; SEPHADEX; TOSYLCHLORAMIDE SODIUM; TRIPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIAGNOSTIC IMAGING; DRUG DESIGN; DRUG DISTRIBUTION; DRUG PURIFICATION; DRUG SYNTHESIS; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ISOTOPE LABELING; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROSTATE CARCINOMA; RADIOIODINATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOLID PHASE SYNTHESIS;

MUS MUSCULUS;

EID: 55349116727     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.1542     Document Type: Article

References (11)

1. G. Bergers, L. E. Benjamin, Nat. Rev. Cancer 2003, 3, 401-410. DOI:10.1038/nrc1093.
2. E. Ruoslahti, Nat. Rev. Cancer 2002, 2, 83-90. DOI :10.1038/nrc724.
3. S. Liu, D. S. Edwards, Chem. Rev. 1999, 99, 2235-2268. DOI: 10.1021/cr980436l.
4. C. K. Brown, R. A. Modzelewski, C. S. Johnson, M. K. Wong, Ann. Surg. Oncol. 2000, 7, 743-749. DOI: 10.1007/s10434-000-0743-0.
5. E. R. Gregory, K. K. Michael, A. Ruth, Cancer Res. 2005, 65, 533-539.
6. D. O. Henry, S. C. Chen, M. K. Wong, J. Clin. Oncol. 2006, 24, 14582.
7. A. N. Mamelak, D. B. Jacoby, Expert Opin. Drug Deliv. 2007, 4, 175-186. DOI: 10.1517/17425247.4.2.175.
8. S. Li, M. Peck-Radosavljevic, O. Kienast, J. Preitfellner, G. Hamilton, A. Kurtaran, C. Pirich, P. Angelberger, R. Dudczak, Ann. Oncol. 2003, 14, 1274-1277. DOI:10.1093/annonc/mdg344.
9. R. Haubner, H. J. Wester, Curr. Pharm. Des. 2004, 10, 1439-1455.
10. J. C. Miller, H. H. Pien, D. Sahani, A. G. Sorensen, J. H. Thrall, J. Natl. Cancer Inst. 2005, 97, 172-187. DOI:10.1093/jnci/dji023.
11. M. Matloobi, H. Rafii, D. Beigi, A. Khalaj, M. K. Dehghan, J. Radioanal. Nucl. Chem. 2003, 257, 71-73. DOI:10.1023/A: 1024741209133.